These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2738589)

  • 1. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):472-6. PubMed ID: 2738589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia.
    Patsalos PN; Elyas AA; Zakrzewska JM
    Eur J Clin Pharmacol; 1990; 39(4):413-5. PubMed ID: 2076729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    Pain; 2002 Feb; 95(3):259-266. PubMed ID: 11839425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia.
    Gomez-Arguelles JM; Dorado R; Sepulveda JM; Herrera A; Arrojo FG; Aragón E; Huete CR; Terrón C; Anciones B
    J Clin Neurosci; 2008 May; 15(5):516-9. PubMed ID: 18378142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain.
    Di Stefano G; La Cesa S; Truini A; Cruccu G
    J Headache Pain; 2014 Jun; 15(1):34. PubMed ID: 24912658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs used in the management of trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):439-50. PubMed ID: 1408017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
    Mogensen PH; Jórgensen L; Boas J; Dam M; Vesterager A; Flesch G; Jensen PK
    Acta Neurol Scand; 1992 Jan; 85(1):14-7. PubMed ID: 1546529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trigeminal neuralgia: its treatment with two new carbamazepine analogues.
    Farago F
    Eur Neurol; 1987; 26(2):73-83. PubMed ID: 3549316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world effectiveness and tolerability of carbamazepine and oxcarbazepine in 354 patients with trigeminal neuralgia.
    Di Stefano G; De Stefano G; Leone C; Di Lionardo A; Di Pietro G; Sgro E; Mollica C; Cruccu G; Truini A
    Eur J Pain; 2021 May; 25(5):1064-1071. PubMed ID: 33428801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine in neuropathic pain.
    Nasreddine W; Beydoun A
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1615-25. PubMed ID: 17922625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations.
    Kristensen O; Klitgaard NA; Jönsson B; Sindrup S
    Acta Neurol Scand; 1983 Sep; 68(3):145-50. PubMed ID: 6650125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent therapeutic effect of carbamazepine-10,11-epoxide in trigeminal neuralgia.
    Tomson T; Bertilsson L
    Arch Neurol; 1984 Jun; 41(6):598-601. PubMed ID: 6721732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unexpected loss of therapeutic effect of oxcarbazepine].
    Lampert ML; Rätz Bravo AE; Brugger S; Haschke M
    Praxis (Bern 1994); 2007 Nov; 96(47):1843-8. PubMed ID: 18062156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on pharmacotherapy for trigeminal neuralgia.
    Pergolizzi JV; LeQuang JA; El-Tallawy SN; Wagner M; Ahmed RS; Varrassi G
    Expert Rev Neurother; 2024 Aug; 24(8):773-786. PubMed ID: 38870050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).
    Besi E; Boniface DR; Cregg R; Zakrzewska JM
    J Headache Pain; 2015; 16():563. PubMed ID: 26335440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and evidence for the use of oxcarbazepine in neuropathic pain.
    Carrazana E; Mikoshiba I
    J Pain Symptom Manage; 2003 May; 25(5 Suppl):S31-5. PubMed ID: 12694990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose dependent enzyme induction by oxcarbazepine?
    Patsalos PN; Zakrzewska JM; Elyas AA
    Eur J Clin Pharmacol; 1990; 39(2):187-8. PubMed ID: 2253672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory trigeminal neuralgia. Non-surgical treatment options.
    Cruccu G; Truini A
    CNS Drugs; 2013 Feb; 27(2):91-6. PubMed ID: 23225488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration.
    Tomson T; Tybring G; Bertilsson L; Ekbom K; Rane A
    Arch Neurol; 1980 Nov; 37(11):699-703. PubMed ID: 7436811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.